Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Condition(s):Solid Tumor; Breast Tumor; Colon Tumor, Malignant; Lung Tumor; Urologic Cancer; Pancreatic Cancer; Melanoma; Metastatic Cancer; Locally Advanced Solid Tumor; Esophageal Cancer; Endometrial Cancer; Head and Neck CancerLast Updated:January 5, 2024Active, not recruiting